If we stay at 14.5c, the Nasdaq should report a $2 share price. If not, and there’s no need, I fear a retrace.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025